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Abstract
Background: Irritable Bowel Syndrome, a highly prevalent chronic disorder, places significant
burden on the health service and the individual. Symptomatic distress and reduced quality of life
are compounded by few efficacious treatments available. As researchers continue to demonstrate
the clinical efficacy of alternative therapies, it would be useful to gain a patient-perspective of
treatment acceptability and identify patient's attitudes towards those modalities considered not
acceptable.
Methods: Six hundred and forty-five participants identified from an earlier IBS-prevalence study
received a postal questionnaire to evaluate preferences and acceptability of nine forms of
treatment. Proportions accepting each form of treatment were calculated and thematic analysis of
qualitative data undertaken.
Results: A total of 256 (39.7%) of 645 potential respondents completed the questionnaire (mean
age 55.9 years, 73% female). Tablets were most acceptable (84%), followed by lifestyle changes (diet
(82%), yoga (77%)). Acupuncture (59%) and suppositories (57%) were less acceptable.
When explaining lack of acceptability, patient views fell into four broad categories: dislike treatment
modality, do not perceive benefit, general barriers and insufficient knowledge. Scepticism, lack of
scientific rationale and fear of CAM were mentioned, although others expressed a dislike of
conventional medical treatments. Past experiences, age and health concerns, and need for proof of
efficacy were reported.
Conclusion: Most patients were willing to accept various forms of treatment. However, the
reservations expressed by this patient-population must be recognised with particular focus
directed towards allaying fears and misconceptions, seeking further evidence base for certain
therapies and incorporating physician support and advice.
Background
Irritable Bowel Syndrome (IBS) is a chronic, relapsing,
gastrointestinal disorder, affecting a substantial propor-
tion of the population, with recent prevalence estimates
between 10.5% and 30% [1-4]. IBS accounts for nearly
3% of general practitioner consultations3  equating to
approximately 1.8 million consultations in Britain per
year[5]. Additionally it is known to have detrimental
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effects on quality of life [6]; effects which have been dem-
onstrated as being similar to those of other common long-
term medical disorders [7]. Symptom control is poor for a
large proportion of patients. Thus it is understandable
that failure of conventional treatment, the poorly under-
stood pathology as well as the psychological components
of IBS, have led to the development of complementary
and alternative therapies targeted at symptom manage-
ment.
Complementary and alternative medicine (CAM)
includes all such practices and ideas outside the domain
of conventional medicine and defined as preventing or
treating illness, or promoting health and well-being [8]. It
is known that chronic disease patients rank high among
CAM users; 50.9% of IBS sufferers are reported to use
CAM [9]. The popularity of CAM has grown significantly
in all modern societies over the past two decades [10],
demonstrated by an increase in general practices offering
access to CAM, 49% in 2001 compared to 39% in 1995
[11]. The Department of Health (UK) has also recognised
its growing significance, particularly in relation to primary
care services. Their 2003 policy document includes recom-
mendations for developing a framework facilitating
patient access to CAM [12].
It is likely that patients have clearly defined preferences for
treatments, both in terms of modality and general theoret-
ical perspective and these preferences may differ between
different subgroups of patients. In western countries,
CAM use is reported to be more frequent in women, well-
educated individuals, and amongst middle-aged rather
than elderly people [13]. One could assume that CAM is
seen as a 'last resort', as many studies have shown that
CAM use is associated with a long illness duration, poor
functional status and co- morbidity [14,15]. However, a
recent study which controlled for other confounders did
not support this [16], suggesting that for some individuals
CAM is a preferred primary management strategy. It is
possible that this will apply more so for conditions per-
ceived as 'non-threatening' but causing significant disrup-
tion to everyday life.
It is not clear to what extent treatment acceptability is
affected by its recommendation by a doctor or health pro-
fessional. It has been reported that a large proportion of
patients (62%) prefer their doctors to discuss non-evi-
dence based treatment options with them, primarily to
offer advice but also in case of interactions with other
medicines [17]. Although this is not always the case, some
patient groups may prefer the medical team to make treat-
ment decisions on their behalf [18]. It is possible that
treatments advised by the doctor may be perceived as
more credible, emphasising the importance of health pro-
fessionals' knowledge and understanding of different
treatment options.
Hypnotherapy and relaxation strategies have been shown
to be effective in clinical trials [19,20] and there is evi-
dence to support efficacy for some forms of herbal therapy
and certain probiotics in IBS [21,22]. However, many
patients still seem adverse to alternative management
strategies [9]. Obviously outcome is not exclusively
important to patients; acceptability may also depend on
the nature and form of delivery of therapy. Promising
therapies may not be worth pursuing if they are unaccept-
able to the majority of patients. Reasons for this have been
under-researched in patients with chronic non-threaten-
ing disease. To date, no information is available on the
attitudes and acceptability of different therapies and
modes of delivery in relation to IBS patients. The primary
aim of this study was to explore the above, and the sec-
ondary aim was to determine whether a patient's willing-
ness to accept a treatment for their IBS is dependent on the
recommendation of a doctor or related to patient charac-
teristics such as age, gender, education level attained or
employment. Findings from this study will not only offer
the health professional insight but also complement exist-
ing knowledge on the efficacy and costs of different treat-
ments to guide therapeutic development.
Methods
Ethical approval
Ethical Approval was granted through the Wolverhamp-
ton Local Research Ethics Committee (Ref 05/QZ701/86).
Setting/sample
In 2000/2001 a large study was conducted in Birming-
ham, to establish the prevalence of IBS in the community
[1]. A postal questionnaire was sent to 8646 patients aged
18 and over, who were randomly selected from the regis-
ters of eight general practices in North and West Birming-
ham. Of those who responded, 1151 (n = 4807) patients
were identified as having a Rome II diagnosis (n = 398)
[23] or two or more symptoms suggestive of IBS (accord-
ing to Rome II) (n = 753). Of these, 892 individuals
responded to an invitation to provide symptom data.
This cohort of patients (n = 892) was followed up in 2006
to explore the epidemiological trends and establish the
natural history of IBS. Patients were excluded (n = 247)
due to terminal illness or other circumstance in which the
GP felt contact was inappropriate (n = 15), including a
recent more significant bowel diagnosis, where they had
transferred GP practice, (so current status could not be
confirmed) (n = 193), or where they were known to be
deceased (n = 39). The 645 remaining patients were re-
contacted and invited to complete a further postal ques-
tionnaire [see Additional file 1], which collected data
about acceptability of a range of treatment options includ-
ing both traditional and conventional forms of delivery
and complementary and alternative strategies.BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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The sample size was limited to responders of previous
questionnaires; therefore no formal sample size calcula-
tion was performed.
Intervention
A questionnaire and free-post return envelope were
mailed to patients. Subjects not wishing to take part in the
study were notified to return a blank copy to avoid further
contact while those failing to respond within 21 days were
sent another questionnaire as a reminder. Patients were
invited to complete the questionnaire as fully as possible
although were not obligated to do so. Questionnaires did
not contain identifiable data but were coded (and there-
fore not anonymous) for administrative purposes. All par-
ticipants were informed of the purpose of the study and
return of a completed questionnaire was deemed to imply
consent.
Outcome measures
Each patient received an identical two-part questionnaire.
The first part elicited information about their IBS symp-
toms and demographic details including age, gender, eth-
nicity, and education level. The second part addressed their
attitudes and acceptability of various treatment options.
Nine types of treatment options which reflected diverse
delivery modalities and a range of underlying belief sys-
tems were presented; taking a tablet (drug therapy), apply-
ing a cream to stomach, suppositories, exercises (similar to
yoga), diet change, acupuncture, hypnotherapy, homeopa-
thy, and application of a heat pad. Patients were asked
whether they would consider each of these treatments
under three different scenarios a) if their doctor recom-
mended the treatment as part of their usual medical care, b)
if the treatment was offered as part of a research study, or c)
if they had to arrange and pay for the treatment themselves.
If they accepted the treatment under any one of these sce-
narios they were categorised as accepting that modality. If
they did not find the treatment acceptable, they were
encouraged to detail in a free text space their reasons.
Questionnaires were reviewed for completeness and
responses entered into a Microsoft Access database. For
the purposes of data entry validation, 10% of the data was
dual entered.
Analysis
Simple description of demographic features of the
respondents and the proportion of patients willing to use
each type and form of treatment was undertaken. Chi-
squared tests were performed to determine whether
acceptability was related to personal characteristics; age,
gender, educational achievement and employment status.
As this involved multiple testing, statistical significance
was considered if p < 0.01. Age was collapsed into two
groups based on group median age (≤55 years and >55
years). Education was categorised as working 20+ hours
per week, working <20 hours per week, and retired/other.
Educational attainment was classified as leaving school at
or before 16 years of age or schooling beyond age 16. Eth-
nicity was not included in the analysis as there were too
few numbers for ethnicities other than Caucasian to allow
statistical testing. Statistical analyses were performed
using SPSS for Windows version 13.0.
Qualitative analysis of written responses in the question-
naires was undertaken with identification of themes
emerging from data relating to reasons for therapeutic
refusal being the primary objective of analysis. A manual
indexing system was applied to all data and eventually
major organising themes were identified to reflect
patients' attitudes to the acceptability of different treat-
ments. Qualitative data was initially coded by one
researcher (LH) with a second researcher (LR) subse-
quently reviewing the emerging themes with reference to
the full data.
Results
Demographic data
Of the 645 patient cohort, 377 responded (58.4%), how-
ever 121 questionnaires were returned with this section of
the questionnaire unanswered; therefore an overall 39.7%
(n = 256) response rate was achieved. Of the responders,
94% were Caucasian, 73% female, and average age was 56
years. Demographics of those who returned the question-
naire were similar to those who did not (Table 1).
Treatment preferences and acceptability
Table 2 displays the number of patients accepting each
treatment modality. The greatest number of patients
accepted medication as a tablet form (84%) followed by a
diet change (82%) and yoga (77%). Seventy six individu-
als were accepting of all modalities and only ten partici-
pants indicated none of the proposed treatment forms
was acceptable to them. Acupuncture (59%) and suppos-
itories (57%) were less accepted. Acceptability of a treat-
ment was greatest in all cases when recommended by a
clinician.
Age was related to accepting yoga (p = 0.01), diet change
(p = 0.02) and hypnotherapy (p = 0.02) but not the other
treatment modalities, with younger respondents (55 years
and under) being more likely to accept such treatment
forms than older respondents.
Gender was not significantly related to accepting any form
of treatment, nor was education level or employment sta-
tus.
When categorising treatments into conventional treat-
ments (tablets, suppositories, creams and heat pad), life-
style (exercises like yoga, diet change) and CAM
(acupuncture, hypnotherapy, homeopathy), age wasBMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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again significantly related to accepting treatments, with
younger patients (age ≤55 years) being more accepting of
lifestyle changes (p = 0.006). Age was not significantly
associated at the p < 0.01 level with acceptance of conven-
tional forms of treatment (p = 0.049) or CAM (p = 0.11).
Qualitative analysis
Reasons for finding a treatment unacceptable
The themes and sub themes that emerged from the data
are displayed in figure 1. The four main themes are
broadly defined as:
1. Dislike treatment modality
2. Do not perceive benefit
3. General barriers (internal factors for example ill health
and external factors such as time and accessibility)
4. Insufficient knowledge
Themes are supported by patient responses. Due to the
questionnaire nature of this study these were mainly short
responses, and have therefore been presented in figures 2,
3 and 4 to prevent disruption of the main body of text.
Supporting quotes are referenced in the text as figure
number followed by quote index.
Dislike treatment modality
General dislike
Regardless of which treatment was chosen, there were
some patients who expressed a general non-specified dis-
like for it, 2a,2b although this seemed more evident in ref-
erence to hypnotherapy, homeopathy and
suppositories.2c,2d,2e Many individuals held fixed precon-
ceptions against such non-mainstream therapies which
they did not expand upon.
This theme was also strongly portrayed in relation to tab-
let medication; some subjects were wary of taking tablets
Table 1: Demographic information
Respondents
(n = 256)
Non-respondents
(n = 389)
P value
Mean age +/- s.d. 55.9 +/- 14.8 years 54.6 +/- 17.4 years 0.30
Sex
Female 188 (73.4%) 274 (70.0%) 0.46
Male 68 (26.6%) 115 (30.0%)
Race
Caucasian 241 (94.1%) 354 (91.0%) 0.19
other 15 (5.9%) 35 (9.0%)
Highest education level achieved Not known – may have changed since baseline data collected N/A
No school or Primary school 10 (3.9%)
Secondary school 168 (65.6%)
University/higher education 77 (30.1%)
Employment status
Part time/full time work 135 (52.8%) Not known – may have changed since baseline data collected N/A
Full time home maker 23 (9.0%)
Retired 62 (24.2%)
Not working: unemployed or due to poor health 33 (12.9%)
Other 3 (1.2%)
Table 2: Number of patients accepting each treatment modality (n = 256)
Type of treatment Accept the treatment under at least 1 of the circumstances Proportion accepting treatment (95% CI)
Tablets 215 83.9% (79.4,88.4)
Diet change 209 81.6% (76.9,86.4)
Yoga 196 76.6% (71.4,81.8)
Stomach cream 173 67.6% (61.9,73.3)
Homeopathy 166 64.8% (59.0, 70.7)
Heat pad 163 63.7% (57.8,69.6)
Hypnotherapy 163 63.7% (57.8,69.6)
Acupuncture 151 59.0% (53.0,65.0)
Suppository 147 57.4% (51.3, 63.5)BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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and preferred to avoid them. 2f,2g Tablets were also seen as
being associated with reliance and dependence. 2h
Prefer an alternative first
Emerging initially in the views of those disliking tablets
there was a group of individuals who expressed the view
that the unacceptability of some treatments was due to
their preference for 'non-medical alternatives' as initial
management. This theme was evident amongst individu-
als rejecting any of the conventional forms of therapy
(tablets, suppositories and creams). This may be because
some perceive IBS as having dietary or psychosocial ele-
ments rather than a 'medical' cause. 2i,2j
Dislike due to side effects
The risk of possible side effects was enough to deter some
patients.2k,2l In the case of tablets, this could be because
they are ingested and therefore perceived as having an
internal action with potential positive or negative effects.
Reasons for treatment unacceptability Figure 1
Reasons for treatment unacceptability.
Reasons for 
treatment being 
unacceptable 
External factors 
Dislike
treatment 
modality 
Do not 
perceive
benefit
General
barriers  
Insufficient 
knowledge 
General
unspecified 
dislike
Prefer an 
alternative first 
Due to side 
effects
Specific reasons 
Inconvenience/
comfort 
Fear of method
Religious
reasons
Disbelief of 
efficacy 
Past experiences 
Satisfaction 
with current 
management
Internal factors
Inappropriate
for symptoms 
Age
Health
Time  
Financial
Psychological 
Requiring more 
information
Wanting proof 
of efficacy  
If a clinician 
recommends itBMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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Side effects were also mentioned as reasons to avoid
creams and suppositories although to a lesser extent than
for tablets. It therefore appeared that treatments perceived
as 'conventional' were related to a perception of greater
risks of side effects.
A diet change was positively regarded as a lifestyle man-
agement option, although this also carried with it some
fear of side effects; the risk of losing weight being one rea-
son why individuals did not find it acceptable. 2m
Reasons which relate to specific treatment methods
Some individuals regarded homeopathy, yoga, acupunc-
ture and hypnotherapy as having a spiritual association
and for religious reasons found these types of treatments
unacceptable. 2n
Personal comfort is particularly important for individuals
when evaluating and considering treatment methods. 2o,2p
An underlying theme common amongst yoga, hypno-
therapy and suppositories was embarrassment and the
existence of personal tolerance thresholds. Suppositories
and stomach creams were also considered to be invasive
and messy. Although heat pads were generally found to be
acceptable, some individuals described problems of con-
venience, practicality and appearance. 2q,2r
Patients described how they were frightened by some of
the treatments. These views centred on hypnotherapy and
acupuncture. 2s,2t,2u,2v The main hesitance associated with
acupuncture was an overwhelming fear of needles and
pain.
Quotes illustrating theme 1: dislike treatment modality Figure 2
Quotes illustrating theme 1: dislike treatment modality.
General unspecified dislike 
a. ‘I just don’t like the idea of a suppository’ 
b. ‘I’d prefer to avoid altogether any form of alternative therapy’ 
c. ‘I just don’t fancy it’ (reference to hypnotherapy) 
d. ‘It’s just not my style’ (reference to both acupuncture and homeopathy) 
e. ‘I don’t think this would work, I just don’t’ (reference to acupuncture) 
f. ‘I prefer to refrain from medication where possible’. 
g. ‘I do not like taking medication, my doctor found it hard trying to get me to take medication for my duodenal 
ulcer’
h. I would not like to depend on drugs’ 
Prefer an alternative first 
i. ‘I would not want to take a medication before other treatments have been tried’ 
j. ‘I’d prefer dietary or alternative methods to chemical’ 
Side effects 
k. ‘frightened it may make me worse’ (referring to tablets) 
l. ‘My symptoms are not bad enough to warrant this and might have other side effects’ 
m. ‘Although I eat well with a varied diet I do not wish to loose weight, which would happen if I reduced dairy 
products’ 
Specific reasons 
n. ‘No alternative therapies where there is a spiritual root’ 
o. I can’t stand being too hot so I think it would get uncomfortable’. 
p. ‘I would find this physically distressing,’ ‘I don’t like anyone messing with my bum, not even me.’ (Referring 
to suppositories) 
q. ‘Stomach already big enough’. ‘ 
r. This might restrict movement and exercise, also may not be viable with work requirements’
s.  ‘I don’t like the fact that your mind goes blank’, 
t. ‘I do not like the thought of not being in control’,  
u. ‘Too many questionable aspects to hypnotherapy’,  
v. ‘What happens if hypnotherapy goes wrong?’ 
w. ‘I haven’t got the will or the energy’. BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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Some treatment modalities, such as yoga, were perceived
to require greater personal commitment, effort, and may
be inconvenient to daily life. 2w
Do not perceive benefit
Disbelief of efficacy
A particularly strong theme evident amongst acupuncture,
homeopathy, and hypnotherapy was a general scepticism
and disbelief in their effectiveness.3a,3b,3c Heat pads and
stomach cream were also regarded with some scepticism
due to their external application which some felt was at
odds with management of an 'internal' problem.3d Percep-
tions of efficacy were stronger for conventional style med-
ications, which could be related to greater knowledge and
experience of mainstream therapies.
Past experiences of use
Past experiences and poor outcomes shaped many
patients attitudes. 3e,3f,3g
Satisfaction with current management
Those patients satisfied with current treatment did not feel
the need to change their practice. 3h,3i
Not appropriate for symptoms
A treatment was considered inappropriate for one of two
reasons. The first was if the individual's symptoms were
not considered severe enough. 3j,3k Some therapies may be
perceived as having more associated risks, and would only
be considered if symptoms were very severe. The second
reason suggested was related to known associations
between treatment types and symptoms. For example,
suppositories were perceived as useful in the management
of constipation but not with diarrhoea. 3l
General barriers to acceptance
Internal factors
Some patients viewed other health problems as a barrier
to using certain therapies, for example co-existing skin dis-
orders such as eczema, psoriasis, and skin allergies were
mentioned as contra-indicating use of creams and heat
pads. 4a
Many health restraints were mentioned in relation to
yoga: pregnancy, poor flexibility, being physically unfit
and a number of back and joint problems. Spine prob-
lems, past operations and paraesthesia discouraged some
individuals from considering acupuncture. Health
restraints for inserting a suppository included anal fis-
sures, piles, arthritis, incontinence and pain in back and
legs. 4b
Age was also used to explain aversion to some therapies.
Being too old was stated as a barrier to yoga therapy. Age
was also indicated to impact on flexibility essential for
applying creams and suppositories and thus the age of the
target population for therapies should certainly be consid-
ered.
Quotes illustrating theme 2: do not perceive benefit Figure 3
Quotes illustrating theme 2: do not perceive benefit.
Disbelief of efficacy 
a. ‘I have no faith in it, I just do not think it would do any good’ 
b. I do not consider homeopathy generally to be a proper scientific approach - my wife had homeopathy for a 
problem - it did nothing to help 
c. I consider this condition physical and not mental’. (referring to hypnotherapy) 
d. ‘Although I am not medically qualified, I don’t feel a cream applied externally could affect an internal organ/ 
system’.
Past experiences of use 
e. ‘My doctor has prescribed two lots of medication which have not resolved my condition’ 
f. ‘I have had acupuncture before and found it useless’ 
g. ‘I have tried many, but don’t like to rely on medications as if you come off it then nothing has changed’ 
Satisfaction with current management 
h. ‘I already carry around a heat pad to alleviate symptoms’. 
i.  ‘Present bowel symptoms are resolved by taking oral laxatives’
Not appropriate for symptoms 
j. ‘It’s not acute enough to really worry me at present’. 
k. ‘If I need help I would seek it but I do not want this to be a major part of my life’ 
l. ‘Surely this would open the bowels more frequently, I need to stop it’ BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
Page 8 of 11
(page number not for citation purposes)
External factors
Other barriers to treatments included time, financial costs
and access. Tablets and creams were generally perceived as
being reasonably expensive whilst acupuncture, hypno-
therapy and yoga as both expensive and time consuming.
In some instances accessibility was the only deterring fac-
tor. 4c
Psychological
Resignation seemed to play a part for some individuals. 4d
Some individuals were prepared to accept their symp-
toms, without seeking relief or cure.
Insufficient knowledge
Requiring more information
Many subjects felt they required more information before
they could make a decision regarding treatments. This
applied primarily to ingested therapies (tablets, homeo-
pathic tablets) but did also apply to most treatments with
an unknown element such as hypnotherapy. 4e,4f
Wanting proof of efficacy
Requiring proof of efficacy was an important and repeated
theme.4g,4h,4iInterestingly this theme emerged more
strongly amongst the conventional treatments such as tab-
lets and suppositories. This may be due to the greater per-
ceived risks of these more intrusive forms of treatment.
If recommended by clinician
Most subjects were more accepting of CAM treatments if
recommended by a clinician.4j This is likely to be due to a
combination of factors related to above themes including
an assumption of efficacy if advised by a clinician, provi-
sion of information about the therapy including side
effects or interactions with concomitant medication, and
individual preference for clinician directed disease man-
agement.
Discussion
Quantitative analyses indicated that the treatments most
strongly endorsed were those most closely aligned with
conventional medicine, notably tablets. Lifestyle changes
Quotes illustrating themes 3 & 4: general barriers to acceptance and insufficient knowledge Figure 4
Quotes illustrating themes 3 & 4: general barriers to acceptance and insufficient knowledge.
Quotes illustrating theme 3 general barriers 
Internal factors 
a. ‘I am very over allergic in many ways. I have bad eczema and have allergic reactions to plasters and 
even my own scratching’
b. ‘The awkwardness in applying this medication (physical awkwardness)’(In individual reporting 
restricted movement)
External factors 
c. ‘as long as I could have it at home.’ 
d. ‘I have lived a long time with this and don’t believe in taking drugs of any kind I’ve got this far 
without and there is no more that can be done than that’. 
Quotes illustrating theme 4 insufficient knowledge 
Requires more information: 
e. ‘I’m not sure about this one- I would need more info first, such as who would be doing this, 
qualifications.’ 
f. ‘I do not know enough about hypnotherapy. I would have to be informed what would be involved in 
the treatment before I make a decision’ 
Wants proof: 
g. ‘I would want 100% guarantee of it working before using it.’ 
h. ‘very unpleasant having a suppository-  would want 100% guarantee of it working before using it’ 
i. ‘only happy with strictly necessary medication that is proven’ 
If recommended by clinician: 
j. ‘I only use alternatives if the doctor says it’s ok to use them. I like to ask advice first, if the answer is 
no, then I don’t use them’ BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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are more favourable than CAM suggesting that preference
for 'a quick fix' is not a primary driver in the choice of ther-
apy. These findings are supported by other literature
which has shown that patients perceive diet and prescrip-
tion medicines to have the greatest benefit for their IBS
[24]. Perhaps lifestyle changes are believed to have fewer
risks and side effects which deterred patients from other
methods of treatment, and with this style of treatment,
patients have greatest control. As patient empowerment is
increasingly more important in modern medical practice,
this could be an area to target within IBS management.
All treatments were accepted by more than half the study
population, supporting the current level of unmet need
and desire to explore therapeutic options in this patient
group. Research in another area of chronic disease man-
agement (chronic pain) reported similar findings; a high
proportion of patients willing to try exercise and inter-
ested in learning relaxation techniques to alleviate symp-
toms [25].
In general, these results do not support prior studies sug-
gesting well-educated, middle aged women are more
accepting of CAM [13]. This may be because this study
presented the options as potentially available and there-
fore obtained a better view of acceptability if barriers of
access and cost are removed. However, age was signifi-
cantly associated with willingness to accept some of the
treatments with younger patients (<56 years) being more
inclined to accept yoga, hypnotherapy and dietary change.
Gender was not associated with willingness to accept any
therapies, in contrast to other studies [13], although this
finding may be attributable to sample size and domi-
nance of female respondents (73%).
The qualitative data suggest that the three forms of treat-
ment modalities present unique barriers to acceptance.
Conventional modalities, (tablets, suppositories, creams)
were rejected as their association with mainstream treat-
ments gives a greater perception of risk and possibility of
side effects. Those who perceived their symptoms as less
severe were less accepting of treatments they believed to
be 'risky' in line with other literature suggesting less severe
symptoms predicts treatment disuse [26].
Conversely CAM modalities may be preferred as they are
'less risky' but were viewed with scepticism, drawing a par-
allel with other literature [26]. Patients wanted more
information and proof of efficacy. Specific modalities
frightened some individuals; fear of needles and hypno-
tism were quoted. Spiritual associations deterred some
individuals who felt this conflicted with their religious
beliefs. Lifestyle changes were generally well accepted;
although require more effort for the individual.
For some individuals time and financial costs were central
to acceptability, as previous research suggests [25]. For
treatments that are more provider-based as opposed to
self-care based, perceived lack of accessibility to providers
also explained unacceptability. Due to the older average
age of this population, age-related health concerns also
featured significantly amongst potential barriers. For skin-
contactable treatments such as creams and heat pads, skin
disorders and allergies were potential barriers. Psycholog-
ical barriers also emerged from this study. Patients who
were resigned to their symptoms were less willing to try
treatments. Hence psychological aspects and patient
cooperation must be considered.
Results from this study showed that patients were more
inclined to accept any of the treatments if recommended
by a physician, reflecting the value assigned to clinician
support. This suggests members of the clinical team may
be ideally positioned to explore patient reservations and
provide education and evidence. Lack of physician sup-
port has been statistically significantly associated with
CAM disuse in other studies [26].
Study limitations
As this data was collected as part of a larger epidemiolog-
ical study and utilised to form a secondary exploratory
study, it is limited by the data available and the popula-
tion demographics of those included.
There were a number of limitations to the study. Firstly,
respondents were mainly Caucasian, and thus data may
not be applicable to other ethnic populations. Also the
limited range of ethnicities and female predominance
limited the statistical ability to compare these. Over sim-
plification of other categories, eg: age, may mean that dif-
ferences between groups have not been identified, but
were undertaken to enable comparative analyses. Sec-
ondly, a 40% response rate is quite low. This may be
explained by the fluctuating nature of IBS; during some
time periods individuals may be symptom free which may
suggest a lower level of commitment to survey research of
this type. A large loss to follow-up reduced the size of the
cohort. However, there was a large initial sample size and
similar demographics between responders and non-
responders. It has been acknowledged that a larger quali-
tative study with a broader sample of patients from a
diverse range of settings could have enhanced the quality
of the data. The overwhelming female representation in
this cohort could limit generalisability of these findings to
male patient groups. Given the greater prevalence of IBS
in females the findings of this study are likely to be repre-
sentative of an IBS population.
As with all qualitative analyses, the introduction of bias by
the researcher remains a possibility. Such bias is believed
to be further reduced by the different experiential back-BMC Complementary and Alternative Medicine 2008, 8:65 http://www.biomedcentral.com/1472-6882/8/65
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grounds on which researchers drew (one clinical and one
non-clinical, and only one with personal experience of
IBS). It is also acknowledged that qualitative analysis from
written responses may introduce bias as some individuals
may find it hard to articulate their views, responses may
have been misinterpreted, or the defined space for com-
ments may have limited respondents.
Conclusion
As acknowledged, IBS represents significant demands on
the health service and is a source of considerable frustra-
tion amongst patients and health care professionals.
Many reasons for which, relate to the absence of univer-
sally accepted and effective treatments. As researchers con-
tinue to demonstrate the clinical efficacy of CAM
therapies, these findings deserve attention because they
highlight potential reasons why patients may be biased
against such therapies. These findings provide a basis for
further research on possible types of treatments with a
long term objective of developing acceptable and effective
interventions for IBS sufferers.
The study demonstrated that most patients were inter-
ested in trying therapeutic options that lie outside the con-
ventional medical spectrum, but a substantial number of
barriers to these were also outlined. From these it seems
that addressing gaps in patient's knowledge, overcoming
specific fears and applying evidence based knowledge
whilst working in conjunction with physicians could
improve management for IBS and subsequently patient
quality of life. Further work in this area, using interview
methods is recommended to more fully explore patient
perceptions and decision making processes.
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